帕瑞昔布钠联合肋间神经阻滞麻醉改善胸腔镜下肺癌患者术后急性疼痛的效果  

作　　者：刘鸿芹[1] 盛一平[1] 张锐[1] 

机构地区：[1]浙江省肿瘤医院,310022

出　　处：《浙江临床医学》2019年第9期1219-1221,共3页Zhejiang Clinical Medical Journal

摘　　要：目的探讨帕瑞昔布钠联合肋间神经阻滞对非小细胞肺癌患者术后急性疼痛控制的效果.方法选取2018年12月至2019年4月择期行胸腔镜下肺癌根治术患者75例,分为观察组29例和对照组46例,观察组术后采用帕瑞昔布钠控制急性疼痛,对照组术后使用静脉自控镇痛泵控制急性疼痛,比较两组镇痛效果、不良反应发生率、镇痛费用.结果观察组术后24h、48h、72h的VAS评分低于对照组(P<0.05),恶心、呕吐低血压发生率低于对照组(P<0.05).结论在非小细胞肺癌术后治疗中采取帕瑞昔布钠联合肋间神经阻滞能有效控制术后急性疼痛,改善患者镇痛体验.Objective To investigate the clinical effect of Parecoxib sodium combined with intercostal nerve block on postoperative pain control in non-small cell lung cancer patients. Method Seventy-five patients who underwent elective lung cancer under thoracoscopy from December 2018 to April 2019 were enrolled in the study,including 29 patients in the observation group and 46 patients in the control group.In the observation group, Parecoxib sodium was used to control acute pain. In the control group,intravenous analgesia pump was used to control acute pain. The analgesic effect, adverse reaction rate and analgesic cost were compared. Results The VAS scores of the intervention group at 24h,48h,and 72h were lower than those of the control group(P<0.05). The incidence of nausea,vomiting,and hypotension was lower in the intervention group than in the control group(P<0.05). Conclusion The use of Parecoxib sodium combined with intercostal nerve block in the treatment of non-small cell lung cancer can effectively control postoperative acute pain and can significantly improve the patient's analgesic experience.

关 键 词：帕瑞昔布钠 肋间神经阻滞 胸腔镜肺癌手术 急性疼痛 

分 类 号：R655[医药卫生—外科学]